Literature DB >> 874779

Binding of codeine, morphine, and methadone to human serum proteins.

J Judis.   

Abstract

The binding properties of codeine, morphine (as representative opium alkaloids), and methadone (a synthetic pharmacologically similar compound) were studied with selected human serum proteins. The methodology involved equilibrium and dynamic dialysis using 3H-and/or 14C-labeled compounds. For estimation of the percent binding with equilibrium dialysis, concentrations of the ligand used were approximately therapeutic blood levels and another concentration 30-60 times higher. The percent binding to whole human serum ranged from about 20% for morphine to almost 60% for methadone. Of the human serum proteins investigated, the highest percent binding was found with albumin, except for methadone for which it was beta-globulin III. The affinity for other serum proteins varied with the ligand. In studies with albumin using dynamic dialysis, the plots of nubar divided by free concentration versus nubar were similar for all three ligands studied and had positive slopes, unlike those reported for acidic compounds for which the slope is always negative. In studies of binding of one ligand in the presence of another, significant competition was demonstrated, suggesting that the same binding sites were involved.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 874779     DOI: 10.1002/jps.2600660615

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

Review 1.  Interpretation of oral fluid tests for drugs of abuse.

Authors:  Edward J Cone; Marilyn A Huestis
Journal:  Ann N Y Acad Sci       Date:  2007-03-01       Impact factor: 5.691

2.  Kinetic analysis of nanoparticulate polyelectrolyte complex interactions with endothelial cells.

Authors:  Sean M Hartig; Rachel R Greene; Gianluca Carlesso; James N Higginbotham; Wasif N Khan; Ales Prokop; Jeffrey M Davidson
Journal:  Biomaterials       Date:  2007-05-03       Impact factor: 12.479

3.  Prediction of drug distribution into human milk from physicochemical characteristics.

Authors:  H C Atkinson; E J Begg
Journal:  Clin Pharmacokinet       Date:  1990-02       Impact factor: 6.447

Review 4.  Disease-induced changes in the plasma binding of basic drugs.

Authors:  K M Piafsky
Journal:  Clin Pharmacokinet       Date:  1980 May-Jun       Impact factor: 6.447

5.  Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients.

Authors:  D J Foster; A A Somogyi; K R Dyer; J M White; F Bochner
Journal:  Br J Clin Pharmacol       Date:  2000-11       Impact factor: 4.335

6.  Infants and young children metabolise codeine to morphine. A study after single and repeated rectal administration.

Authors:  H Quiding; G L Olsson; L O Boreus; U Bondesson
Journal:  Br J Clin Pharmacol       Date:  1992-01       Impact factor: 4.335

7.  Electrochemical Detection of Morphine in Untreated Human Capillary Whole Blood.

Authors:  Elsi Verrinder; Niklas Wester; Elli Leppänen; Tuomas Lilius; Eija Kalso; Bjo Rn Mikladal; Ilkka Varjos; Jari Koskinen; Tomi Laurila
Journal:  ACS Omega       Date:  2021-04-21

8.  Methadone adverse reaction presenting with large increase in plasma methadone binding: a case series.

Authors:  Wenjie J Lu; Weidong Zhou; Yvonne Kreutz; David A Flockhart
Journal:  J Med Case Rep       Date:  2011-10-10

9.  Morphine Binds Creatine Kinase B and Inhibits Its Activity.

Authors:  Ivan Weinsanto; Jinane Mouheiche; Alexis Laux-Biehlmann; François Delalande; Arnaud Marquette; Virginie Chavant; Florian Gabel; Sarah Cianferani; Alexandre Charlet; Marie-Odile Parat; Yannick Goumon
Journal:  Front Cell Neurosci       Date:  2018-12-03       Impact factor: 5.505

10.  Simultaneous Detection of Morphine and Codeine in the Presence of Ascorbic Acid and Uric Acid and in Human Plasma at Nafion Single-Walled Carbon Nanotube Thin-Film Electrode.

Authors:  Niklas Wester; Elsi Mynttinen; Jarkko Etula; Tuomas Lilius; Eija Kalso; Esko I Kauppinen; Tomi Laurila; Jari Koskinen
Journal:  ACS Omega       Date:  2019-10-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.